Biofrontera Inc. (BFRI) vs Dare Bioscience, Inc. (DARE)
A side-by-side comparison of Biofrontera Inc. and Dare Bioscience, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BFRI
Biofrontera Inc.
$0.89HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
DARE
Dare Bioscience, Inc.
$0.84HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — BFRI vs DARE
growth of $100 · dividends reinvested · last 5yBFRI -99.0% (-60.1%/yr)DARE -95.1% (-45.2%/yr)DARE compounded faster over this window
BFRI DARE
BFRI vs DARE: by the numbers
- •DARE is the larger company ($13M vs $11M market cap).
- •Both run net losses; BFRI's is the smaller (-13.78% vs -804.37% net margin).
Metrics side by side
Valuation
| Metric | BFRI | DARE |
|---|---|---|
| P/S ratio | 0.25 | 9.25 |
| P/B ratio | 1.92 | N/A |
Profitability
| Metric | BFRI | DARE |
|---|---|---|
| Gross margin | 84.45% | -137.55% |
| Operating margin | -21.94% | -1315.51% |
| Net margin | -13.78% | -804.37% |
| ROE | -106.87% | N/A |
| ROIC | -32.27% | -203.50% |
Growth (annualized)
| Metric | BFRI | DARE |
|---|---|---|
| Revenue CAGR (5Y) | 15.55% | N/A |
| Total return CAGR (5Y) | N/A | -46.35% |
Go deeper
Dig into the metrics
Biofrontera ROEDare Bioscience ROEBiofrontera operating marginDare Bioscience operating marginBiofrontera revenue growthDare Bioscience revenue growthBiofrontera free cash flowDare Bioscience free cash flow
Biofrontera & Dare Bioscience appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.